Search
NewAmsterdam Pharma Company NV
NAMSAdd to Watchlist
33.890USD
+0.020+0.06%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
3.96BMarket Cap
LossP/E TTM
NewAmsterdam Pharma Company NV's Company Valuation
Currency: USD Updated: 2026-06-30The current valuation score of NewAmsterdam Pharma Company NV is 8.97, ranking 66 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -19.05, which is -89.19% below the recent high of -2.06 and -33.02% above the recent low of -25.35.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.